Fundraising Fox
Cyanocapture
Founded 2021 · 12 employees on LinkedIn · 1 known investors
Find your way into Cyanocapture
Sign up to see every warm intro you have to Cyanocapture
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cyanocapture team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
CyanoCapture develops a synthetic biology platform using genetically engineered photosynthetic cells that convert CO2 into high-value molecules such as enzymes, growth factors, peptides, bioplastics, and drug compounds. The company targets biomanufacturing and critical supply chain applications through a zero-sugar, CO2-based production process.
Investors · 1
Frequently asked questions
- What does Cyanocapture do?
- CyanoCapture develops a synthetic biology platform using genetically engineered photosynthetic cells that convert CO2 into high-value molecules such as enzymes, growth factors, peptides, bioplastics, and drug compounds. The company targets biomanufacturing and critical supply chain applications through a zero-sugar, CO2-based production process.
- Who are Cyanocapture's investors?
- Cyanocapture's investors include Moonstone Venture Capital.